✦ LIBER ✦

A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality

✍ Scribed by Alan J. Cooper

Book ID: 115841451
Publisher: Elsevier Science
Year: 1981
Tongue: English
Weight: 615 KB
Volume: 22
Category: Article
ISSN: 1532-8384
DOI: 10.1016/0010-440x(81)90034-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiandrogen (Cyproterone Acetate) Thera

Antiandrogen (Cyproterone Acetate) Therapy in Deviant Hypersexuality

✍ COOPER, A. J.; ISMAIL, A. A. A.; PHANJOO, A. L.; LOVE, D. L. 📂 Article 📅 1972 🏛 The Royal College of Psychiatrists 🌐 English ⚖ 895 KB

A prospective randomised controlled tria

A prospective randomised controlled trial of tamoxifen and cyproterone acetate in pancreatic carcinoma

✍ Keating, JJ; Johnson, PJ; Cochrane, AMG; Gazzard, BG; Krasner, N; Smith, PM; Tre 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 632 KB

A critical appraisal of the effects of t

A critical appraisal of the effects of the antiandrogen, cyproterone acetate, on the epididymis in connection with fertility control in the male

✍ R.K. Rastogi 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 518 KB

A double blind placebo controlled trial

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia

✍ Downer, S; Joel, S; Allbright, A; Plant, H; Stubbs, L; Talbot, D; Slevin, M 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 874 KB

Effects of the antiandrogens cyproterone

Effects of the antiandrogens cyproterone acetate and flutamide on male reproductive behavior in a lizard (Anolis sagrei)

✍ Richard R. Tokarz 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 1023 KB

Glatiramer acetate in primary progressiv

Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial

✍ Jerry S. Wolinsky; Ponnada A. Narayana; Paul O'Connor; Patricia K. Coyle; Corey 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 2 views

## Abstract ## Objective To determine whether glatiramer acetate (GA) slows accumulation of disability in primary progressive multiple sclerosis. ## Methods A total of 943 patients with primary progressive multiple sclerosis were randomized to GA or placebo (PBO) in this 3‐year, double‐blind tri